2017
DOI: 10.23937/2572-4142/3/1
View full text
|
|
Share

Abstract: Background and aim: The standard treatment of patients with COPD comprises β 2-agonists and anticholinergics. Both drugs exert similar effects in terms of bronchodilation but in the clinical use we observed that some patients reported a stable degree or even an increase of dyspnea after the administration of β 2-agonists compared to anticholinergics. We hypothesized that β 2-agonists might favor an additional change in breathing pattern leading to increased minute volume and respiratory rate, and thereby a sma…

Expand abstract

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals